Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

The sound of migration: exploring data sonification as a means of interpreting multivariate salmon movement datasets.

Hegg JC, Middleton J, Robertson BL, Kennedy BP.

Heliyon. 2018 Mar 1;4(2):e00532. doi: 10.1016/j.heliyon.2018.e00532. eCollection 2018 Feb.

2.

Local habitat conditions explain the variation in the strength of self-thinning in a stream salmonid.

Myrvold KM, Kennedy BP.

Ecol Evol. 2015 Aug;5(16):3231-42. doi: 10.1002/ece3.1591. Epub 2015 Jul 15.

3.

Diverse Early Life-History Strategies in Migratory Amazonian Catfish: Implications for Conservation and Management.

Hegg JC, Giarrizzo T, Kennedy BP.

PLoS One. 2015 Jul 8;10(7):e0129697. doi: 10.1371/journal.pone.0129697. eCollection 2015.

4.

Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis.

Harding SV, Bateman KP, Kennedy BP, Rideout TC, Jones PJ.

BMC Res Notes. 2015 Feb 23;8:49. doi: 10.1186/s13104-015-1016-0.

5.

Using otolith chemical and structural analysis to investigate reservoir habitat use by juvenile Chinook salmon Oncorhynchus tshawytscha.

Bourret SL, Kennedy BP, Caudill CC, Chittaro PM.

J Fish Biol. 2014 Nov;85(5):1507-25. doi: 10.1111/jfb.12505. Epub 2014 Sep 17.

PMID:
25229130
6.

Spatial structuring of an evolving life-history strategy under altered environmental conditions.

Hegg JC, Kennedy BP, Chittaro PM, Zabel RW.

Oecologia. 2013 Aug;172(4):1017-29. doi: 10.1007/s00442-012-2564-9. Epub 2013 Feb 20.

PMID:
23423520
7.

Juvenile dispersal affects straying behaviors of adults in a migratory population.

Hamann EJ, Kennedy BP.

Ecology. 2012 Apr;93(4):733-40.

PMID:
22690624
8.

Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.

Jacobs RL, Zhao Y, Koonen DP, Sletten T, Su B, Lingrell S, Cao G, Peake DA, Kuo MS, Proctor SD, Kennedy BP, Dyck JR, Vance DE.

J Biol Chem. 2010 Jul 16;285(29):22403-13. doi: 10.1074/jbc.M110.108514. Epub 2010 May 7.

9.

The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.

Mamane Y, Chung Chan C, Lavallee G, Morin N, Xu LJ, Huang J, Gordon R, Thomas W, Lamb J, Schadt EE, Kennedy BP, Mancini JA.

Diabetes. 2009 Sep;58(9):2006-17. doi: 10.2337/db09-0323. Epub 2009 Jul 6.

10.

Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin II production.

Melnyk RA, Tam J, Boie Y, Kennedy BP, Percival MD.

Am J Nephrol. 2009;30(3):232-43. doi: 10.1159/000220260. Epub 2009 May 19.

PMID:
19451703
11.
12.

Adrenergic polymorphism and the human stress response.

Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, Rana BK, Das M, Rodriguez-Flores JL, Smith DW, Cadman PE, Salem RM, Mahata SK, Schork NJ, Taupenot L, Ziegler MG, O'Connor DT.

Ann N Y Acad Sci. 2008 Dec;1148:282-96. doi: 10.1196/annals.1410.085.

13.

Habitat-mediated foraging limitations drive survival bottlenecks for juvenile salmon.

Kennedy BP, Nislow KH, Folt CL.

Ecology. 2008 Sep;89(9):2529-41.

PMID:
18831174
14.

Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor.

Han Y, Belley M, Bayly CI, Colucci J, Dufresne C, Giroux A, Lau CK, Leblanc Y, McKay D, Therien M, Wilson MC, Skorey K, Chan CC, Scapin G, Kennedy BP.

Bioorg Med Chem Lett. 2008 Jun 1;18(11):3200-5. doi: 10.1016/j.bmcl.2008.04.064. Epub 2008 Apr 29.

PMID:
18477508
15.

Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo.

Rao F, Zhang L, Wessel J, Zhang K, Wen G, Kennedy BP, Rana BK, Das M, Rodriguez-Flores JL, Smith DW, Cadman PE, Salem RM, Mahata SK, Schork NJ, Taupenot L, Ziegler MG, O'Connor DT.

Circulation. 2007 Aug 28;116(9):993-1006. Epub 2007 Aug 13.

PMID:
17698732
16.

Basal activation of p70S6K results in adipose-specific insulin resistance in protein-tyrosine phosphatase 1B -/- mice.

Ruffolo SC, Forsell PK, Yuan X, Desmarais S, Himms-Hagen J, Cromlish W, Wong KK, Kennedy BP.

J Biol Chem. 2007 Oct 19;282(42):30423-33. Epub 2007 Jul 30.

17.

Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension.

Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Salem RM, Stridsberg M, Abel K, Smith DW, Eskin E, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT.

Circulation. 2007 May 1;115(17):2271-81. Epub 2007 Apr 16.

PMID:
17438154
18.

Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism.

Rao F, Wessel J, Wen G, Zhang L, Rana BK, Kennedy BP, Greenwood TA, Salem RM, Chen Y, Khandrika S, Hamilton BA, Smith DW, Holstein-Rathlou NH, Ziegler MG, Schork NJ, O'Connor DT.

Hypertension. 2007 May;49(5):1015-31. Epub 2007 Mar 12.

PMID:
17353515
19.

Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.

Julien SG, Dubé N, Read M, Penney J, Paquet M, Han Y, Kennedy BP, Muller WJ, Tremblay ML.

Nat Genet. 2007 Mar;39(3):338-46. Epub 2007 Jan 28.

PMID:
17259984
20.

C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci.

Wessel J, Moratorio G, Rao F, Mahata M, Zhang L, Greene W, Rana BK, Kennedy BP, Khandrika S, Huang P, Lillie EO, Shih PA, Smith DW, Wen G, Hamilton BA, Ziegler MG, Witztum JL, Schork NJ, Schmid-Schönbein GW, O'Connor DT.

J Hypertens. 2007 Feb;25(2):329-43.

PMID:
17211240
21.

PTP1B-dependent insulin receptor phosphorylation/residency in the endocytic recycling compartment of CHO-IR cells.

Cromlish WA, Tang M, Kyskan R, Tran L, Kennedy BP.

Biochem Pharmacol. 2006 Nov 15;72(10):1279-92. Epub 2006 Sep 7.

PMID:
16956584
22.

Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity.

Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP, Lillie EO, Ziegler MG, Smith DW, Schork NJ, Brown JH, O'Connor DT.

Hypertension. 2006 May;47(5):937-47. Epub 2006 Apr 3.

PMID:
16585408
23.

Conformation-assisted inhibition of protein-tyrosine phosphatase-1B elicits inhibitor selectivity over T-cell protein-tyrosine phosphatase.

Asante-Appiah E, Patel S, Desponts C, Taylor JM, Lau C, Dufresne C, Therien M, Friesen R, Becker JW, Leblanc Y, Kennedy BP, Scapin G.

J Biol Chem. 2006 Mar 24;281(12):8010-5. Epub 2006 Jan 6.

24.
25.

Residues distant from the active site influence protein-tyrosine phosphatase 1B inhibitor binding.

Montalibet J, Skorey K, McKay D, Scapin G, Asante-Appiah E, Kennedy BP.

J Biol Chem. 2006 Feb 24;281(8):5258-66. Epub 2005 Dec 6.

26.

Contributions of the sympathetic nervous system, glutathione, body mass and gender to blood pressure increase with normal aging: influence of heredity.

Kennedy BP, Rao F, Botiglieri T, Sharma S, Lillie EO, Ziegler MG, O'connor DT.

J Hum Hypertens. 2005 Dec;19(12):951-69.

PMID:
16195709
27.

Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK.

J Clin Invest. 2005 Jul;115(7):1942-52.

28.

oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes.

Ho Sui SJ, Mortimer JR, Arenillas DJ, Brumm J, Walsh CJ, Kennedy BP, Wasserman WW.

Nucleic Acids Res. 2005 Jun 2;33(10):3154-64. Print 2005.

29.

Protein tyrosine phosphatase: enzymatic assays.

Montalibet J, Skorey KI, Kennedy BP.

Methods. 2005 Jan;35(1):2-8. Review.

PMID:
15588980
30.

Using yeast to screen for inhibitors of protein tyrosine phosphatase 1B.

Montalibet J, Kennedy BP.

Biochem Pharmacol. 2004 Nov 1;68(9):1807-14.

PMID:
15450946
31.

Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: prediction of catecholamines and response to stress in twins.

Zhang L, Rao F, Wessel J, Kennedy BP, Rana BK, Taupenot L, Lillie EO, Cockburn M, Schork NJ, Ziegler MG, O'Connor DT.

Physiol Genomics. 2004 Nov 17;19(3):277-91. Epub 2004 Sep 14.

PMID:
15367723
32.

Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism.

Le Corre P, Parmer RJ, Kailasam MT, Kennedy BP, Skaar TP, Ho H, Leverge R, Smith DW, Ziegler MG, Insel PA, Schork NJ, Flockhart DA, O'connor DT.

Clin Pharmacol Ther. 2004 Aug;76(2):139-53.

PMID:
15289791
33.

Elevated S-adenosylhomocysteine in Alzheimer brain: influence on methyltransferases and cognitive function.

Kennedy BP, Bottiglieri T, Arning E, Ziegler MG, Hansen LA, Masliah E.

J Neural Transm (Vienna). 2004 Apr;111(4):547-67. Epub 2004 Feb 4.

PMID:
15057524
34.

Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors.

Lau CK, Bayly CI, Gauthier JY, Li CS, Therien M, Asante-Appiah E, Cromlish W, Boie Y, Forghani F, Desmarais S, Wang Q, Skorey K, Waddleton D, Payette P, Ramachandran C, Kennedy BP, Scapin G.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):1043-8.

PMID:
15013020
35.

The development of potent non-peptidic PTP-1B inhibitors.

Dufresne C, Roy P, Wang Z, Asante-Appiah E, Cromlish W, Boie Y, Forghani F, Desmarais S, Wang Q, Skorey K, Waddleton D, Ramachandran C, Kennedy BP, Xu L, Gordon R, Chan CC, Leblanc Y.

Bioorg Med Chem Lett. 2004 Feb 23;14(4):1039-42.

PMID:
15013019
36.

Protein tyrosine phosphatase-1B dephosphorylation of the insulin receptor occurs in a perinuclear endosome compartment in human embryonic kidney 293 cells.

Romsicki Y, Reece M, Gauthier JY, Asante-Appiah E, Kennedy BP.

J Biol Chem. 2004 Mar 26;279(13):12868-75. Epub 2004 Jan 13.

37.

Persistence of the lactate paradox over 8 weeks at 3,800 m.

Pronk M, Tiemessen I, Hupperets MD, Kennedy BP, Powell FL, Hopkins SR, Wagner PD.

High Alt Med Biol. 2003 Winter;4(4):431-43.

PMID:
14672546
38.

The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.

Scapin G, Patel SB, Becker JW, Wang Q, Desponts C, Waddleton D, Skorey K, Cromlish W, Bayly C, Therien M, Gauthier JY, Li CS, Lau CK, Ramachandran C, Kennedy BP, Asante-Appiah E.

Biochemistry. 2003 Oct 7;42(39):11451-9.

PMID:
14516196
39.

Immune cell CD62L and CD11a expression in response to a psychological stressor in human hypertension.

Mills PJ, Farag NH, Hong S, Kennedy BP, Berry CC, Ziegler MG.

Brain Behav Immun. 2003 Aug;17(4):260-7.

PMID:
12831828
40.

Relationship of systolic blood pressure with plasma homocysteine: importance of smoking status.

Kennedy BP, Farag NH, Ziegler MG, Mills PJ.

J Hypertens. 2003 Jul;21(7):1307-12.

PMID:
12817177
41.

Early and persistent alterations in prefrontal cortex MAO A and B in Alzheimer's disease.

Kennedy BP, Ziegler MG, Alford M, Hansen LA, Thal LJ, Masliah E.

J Neural Transm (Vienna). 2003 Jul;110(7):789-801.

PMID:
12811639
42.
43.

Functional characterization and crystal structure of the C215D mutant of protein-tyrosine phosphatase-1B.

Romsicki Y, Scapin G, Beaulieu-Audy V, Patel S, Becker JW, Kennedy BP, Asante-Appiah E.

J Biol Chem. 2003 Aug 1;278(31):29009-15. Epub 2003 May 13.

44.
45.

Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity.

Ramachandran C, Kennedy BP.

Curr Top Med Chem. 2003;3(7):749-57. Review.

PMID:
12678842
46.

Protein tyrosine phosphatases: the quest for negative regulators of insulin action.

Asante-Appiah E, Kennedy BP.

Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E663-70. Review.

47.

Human autonomic activity and its response to acute oxygen supplement after high altitude acclimatization.

Bao X, Kennedy BP, Hopkins SR, Bogaard HJ, Wagner PD, Ziegler MG.

Auton Neurosci. 2002 Nov 29;102(1-2):54-9.

PMID:
12492136
48.

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.

O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ.

Ann N Y Acad Sci. 2002 Oct;971:533-5. No abstract available.

PMID:
12438176
49.

Agonist-stimulated neuropeptide and catecholamine release from bovine adrenal chromaffin cells.

Bundey RA, Toneff T, Pottenger J, Kennedy BP, Ziegler MG, Hook VY.

Ann N Y Acad Sci. 2002 Oct;971:338-40. No abstract available.

PMID:
12438146
50.

Location, development, control, and function of extraadrenal phenylethanolamine N-methyltransferase.

Ziegler MG, Bao X, Kennedy BP, Joyner A, Enns R.

Ann N Y Acad Sci. 2002 Oct;971:76-82. Review.

PMID:
12438093

Supplemental Content

Loading ...
Support Center